Case Details
- Title: Cordlife Group Ltd v Cryoviva Singapore Pte Ltd
- Citation: [2016] SGHCR 5
- Court: High Court of the Republic of Singapore
- Date: 15 April 2016
- Judges: Nicholas Poon AR
- Coram: Nicholas Poon AR
- Case Number: Suit No 91 of 2014 (Assessment of Damages No 15 of 2015)
- Decision Type: Assessment of damages following Consent Order
- Plaintiff/Applicant: Cordlife Group Limited
- Defendant/Respondent: Cryoviva Singapore Pte Ltd
- Legal Areas: Damages — assessment
- Procedural Posture: Damages assessed pursuant to a Consent Order dated 24 January 2014 after settlement of claims for trade mark and copyright infringement and passing off
- Key Remedies Sought in Assessment: General damages (loss of profit; loss of reputation/goodwill), special damages (investigation costs), additional damages under s 119(4) of the Copyright Act, and exemplary damages
- Amount Claimed: At least $543,375.63
- Amount Awarded: $63,904.63
- Counsel for Plaintiff: Melanie Ho, Chang Man Phing and Jocelyn Ngiam (WongPartnership LLP)
- Counsel for Defendant: Low Chai Chong, Alvin Liong and Crystal Goh (Rodyk & Davidson LLP)
- Judgment Length: 28 pages, 11,736 words
- Statutes Referenced (as per metadata): Australian Copyright Act; Australian Copyright Act 1968; Copyright Act; Trade Marks Act; and references to “Defendant cease operation of the Trial and Act”, “The Plaintiff came to know of the Act”, “The other infringements complained of in the Act”, “Trial and Act” (as reflected in the provided metadata)
- Copyright Provisions Specifically Discussed (from extract): s 119(3) and s 119(4) of the Copyright Act (Cap 63, 2006 Rev Ed)
Summary
Cordlife Group Ltd v Cryoviva Singapore Pte Ltd [2016] SGHCR 5 is a High Court decision assessing damages after the parties settled liability for trade mark and copyright infringement and passing off. The dispute arose from the defendant’s use of content and “getup” from the plaintiff’s website in two versions of its own website: a “Trial website” (a mock-up) and an “Actual website” that went live later. Although the defendant agreed to pay damages under a Consent Order, the parties could not agree on the extent of infringement and the quantum of damages, leading to a court assessment.
The court awarded the plaintiff $63,904.63, substantially lower than the plaintiff’s claim of at least $543,375.63. The decision emphasises the need for objective proof of loss—particularly for claims for loss of reputation and goodwill—and careful analysis of the appropriate measure of relief for copyright infringement. The court also declined to award additional or exemplary damages on the facts, finding that the infringements, while wrongful, did not justify the higher punitive-style awards sought.
What Were the Facts of This Case?
The plaintiff, Cordlife Group Limited, operates a private cord blood bank in Singapore. It was incorporated on 2 May 2001, began operations in 2002, and has been listed on the mainboard of the Singapore Exchange since 29 March 2012. The defendant, Cryoviva Singapore Pte Ltd, was incorporated on 26 July 2013 with the intention of entering the private cord blood banking business in Singapore. At the relevant time, Cordlife’s CEO was Mr Jeremy Yee and its CFO was Ms Thet Hnin Yi, while Cryoviva’s CEO was Dr Ashish Munjal.
In preparation for its launch, Cryoviva engaged a third-party vendor, Maverick Innovations Pvt Ltd (“Maverick”), to design and create its website. Between late August 2013 and October 2013 (a period disputed between the parties), Cryoviva’s “Trial website” went live at the web address http://www.cryoviva.com.sg/trial/. The Trial website was intended to be a mock-up of the defendant’s final website. The “Actual website” later went live on or around 27 December 2013 at http://www.cryoviva.com.sg/.
Cordlife became aware of the Actual website around 30 December 2013 and also discovered the existence of the Trial website thereafter. Cordlife’s case was that by 14 January 2014, after its staff had reviewed the Trial and Actual websites, it was clear that Cryoviva had used Cordlife’s proprietary information and intellectual property without knowledge or consent. Cordlife alleged three categories of wrongdoing: (i) trade mark infringement by the Trial website, (ii) copyright infringement by both Trial and Actual websites through reproduction of electronic forms, content and “getup” from Cordlife’s website, and (iii) passing off by using Cordlife’s trade mark and replicating the website getup to represent an association with Cordlife.
On 20 January 2014, Cordlife’s solicitors wrote to Cryoviva demanding, among other things, that Cryoviva cease operation of both the Trial and Actual websites. Cordlife then took out an application for an interim injunction on 22 January 2014 to restrain Cryoviva from reinstating the Trial website and from operating the Actual website. However, the parties settled quickly. On 24 January 2014, a Consent Order was entered. Under that Consent Order, Cryoviva agreed to pay damages for trade mark infringement (Trial website), copyright infringement (Trial and Actual websites), and passing off (Trial and Actual websites). The Consent Order further provided that the extent of infringement and the quantum of damages would be decided by the court if the parties could not agree. As part of the settlement, Cryoviva also published a public apology in major local newspapers on 27 and 28 February 2014 acknowledging that it had infringed Cordlife’s intellectual property rights through Trial and Actual websites containing material copied from and/or similar to Cordlife’s website.
What Were the Key Legal Issues?
The assessment turned on three main issues. First, the court had to determine whether Cordlife had proved its claimed losses—loss of profit, loss of business reputation and goodwill, and costs of investigations—and, if so, whether those losses were attributable to the infringements and passing off. This was essentially a combined question of proof and causation.
Second, the court had to address the copyright-specific remedy. Cryoviva argued that the appropriate response to copyright infringement was damages representing the cost of obtaining a licence for the copyrighted work, and that Cordlife was not entitled to damages because the infringements were “innocently committed” such that, under s 119(3) of the Copyright Act, the remedy should be an account of profits rather than damages. This issue required the court to consider both the measure of relief and the relevance of innocence.
Third, the court had to decide whether the character of the infringements and Cryoviva’s conduct justified additional damages under s 119(4) of the Copyright Act and whether exemplary damages should be awarded. These questions required the court to evaluate the seriousness of the infringement and the conduct of the defendant in pursuing or rectifying the wrongful conduct.
How Did the Court Analyse the Issues?
Issue 1: Proof of loss and causation The court approached Issue 1 in two stages: (a) whether Cordlife suffered the losses it claimed, and (b) whether those losses were caused by the defendant’s infringements and passing off. The court began with the head of loss relating to business reputation and goodwill, because it was central to the plaintiff’s general damages claim.
On the evidence, Cordlife relied on four factors to infer reputational harm: (i) a disparity in quality between Cordlife and Cryoviva’s services, (ii) Cordlife’s substantial investment in facilities to achieve accreditation (more than $1.5 million from 2012 to 2015), (iii) Cordlife’s significant advertising and promotion expenditure (approximately $2.7 million in fiscal year 2013), and (iv) the greater impact of online infringement because the internet has immense reach. The court accepted that online infringement can have wide reach, but it held that these factors did not objectively prove that Cordlife had suffered a quantifiable loss of reputation and goodwill.
In particular, the court found that there was no evidence of any disparity in quality between the parties’ products and services. It relied on the principle articulated in Mopi Pte Ltd v Central Mercantile Corp (S) Ltd [2005] SGHC 183 that damages for loss of reputation arising from passing off and trade mark infringement are not automatically synonymous with damages for differences in quality; “surer evidence” is required of the nature of the alleged inferiority and the degree of inferiority that translates into monetary loss. Thus, even if Cordlife had more accredited facilities, that fact alone did not establish that customers associated Cryoviva with inferior quality in a way that caused reputational damage.
The court also discounted the affidavit evidence of Cordlife’s CEO and CFO as bare assertions. Their statements that Cordlife’s reputation was “severely impacted” and that it lost potential customers because of association were not supported by objective proof. The court therefore declined to award $100,000 for loss of reputation and goodwill on the basis of speculation.
Cordlife attempted to rely on Converse Inc v Ramesh Ramchandani and another [2014] SGHCR 11, where an assistant registrar awarded “statutory damages” for losses including loss of reputation even though the plaintiff did not adduce real evidence of that loss. The court distinguished Converse. It noted that in Converse, the trade mark infringement involved counterfeit goods, which in principle could dilute the exclusivity of the brand and thus reputational harm could be inferred even without direct proof. More critically, the statutory basis in Converse (as reflected in the extract) was not applicable in the present case. Accordingly, the court held that the evidential gap in Cordlife’s case could not be cured by analogy.
Although the extract provided is truncated after this point, the court’s overall approach to Issue 1 is clear from the reasoning visible: where the plaintiff seeks substantial damages for reputational harm and loss of profit, it must provide objective evidence and establish causation. The court’s final award of $63,904.63—far below the claimed $543,375.63—reflects that many of Cordlife’s claimed heads of loss were either not proven or not shown to be caused by the infringements and passing off.
Issue 2: Copyright remedy and “innocence” Cryoviva’s copyright submissions were twofold. First, it argued that the appropriate measure of damages should be the cost of obtaining a licence for the copyrighted works, but it contended that Cordlife did not plead or adduce evidence to support the substantiality of any licence fee. Second, Cryoviva argued that under s 119(3) of the Copyright Act, Cordlife was not entitled to damages because the infringements were innocently committed. Cryoviva claimed it was unaware, and had no reasonable grounds for suspecting, that Maverick had reproduced Cordlife’s materials. On that basis, Cryoviva submitted that the appropriate remedy should be an account of profits (limited to profits made by Cryoviva on two contracts during the relevant infringement period) rather than damages.
The court’s analysis in this area would have required it to interpret s 119(3) and determine whether the defendant’s state of knowledge and reasonable grounds met the statutory threshold for “innocent” infringement. The court also had to decide whether the plaintiff’s claim for damages should be replaced by an account of profits, and whether the “licence fee” approach was applicable on the evidence. The ultimate award being modest compared to the claim suggests the court did not accept that Cordlife was entitled to the full damages framework it sought, and it likely treated the copyright infringement as wrongful but not at a level that justified the higher damages claimed.
Issue 3: Additional and exemplary damages Cordlife sought additional damages under s 119(4) of the Copyright Act and also claimed exemplary damages. The plaintiff’s position was that the infringements were flagrant and persisted even after the Consent Order, justifying additional damages of at least $100,000, and that Cryoviva’s conduct in pursuing the infringements warranted exemplary damages of at least $100,000.
Cryoviva rejected these claims. It reiterated that the infringements were innocently caused by Maverick without Cryoviva’s knowledge, and that once Cryoviva discovered the infringements, it took immediate steps to rectify the situation and address Cordlife’s concerns. This conduct, Cryoviva argued, should negate any basis for additional or exemplary damages.
The court’s final award indicates that it did not find the statutory and common law thresholds for additional and exemplary damages to be satisfied. In practical terms, the decision signals that additional damages and exemplary damages are not automatic consequences of infringement. They require a more robust evidential foundation showing flagrance, persistence, or culpable conduct beyond the mere fact of infringement.
What Was the Outcome?
The High Court awarded Cordlife $63,904.63 in damages. This was significantly lower than the amount claimed, reflecting the court’s findings on proof of loss, causation, and the appropriate measure of relief for copyright infringement.
While the Consent Order had already established liability for trade mark infringement (Trial website), copyright infringement (Trial and Actual websites), and passing off (Trial and Actual websites), the assessment stage narrowed the quantum substantially. The court’s approach underscores that even where infringement is conceded or established, damages must still be supported by evidence and must be causally linked to the infringement.
Why Does This Case Matter?
This case is important for practitioners because it illustrates how Singapore courts handle damages assessments after settlement. The Consent Order in Cordlife v Cryoviva resolved liability but left open the extent of infringement and quantum. The decision therefore provides a practical roadmap for what evidence is required at the assessment stage, particularly for claims for loss of profit and reputational harm.
First, the judgment reinforces that claims for loss of business reputation and goodwill require more than general assertions. Courts will look for objective evidence of quality disparity, customer perception, and a demonstrable link between infringement and commercial harm. The court’s reliance on Mopi and its distinction from Converse show that plaintiffs cannot assume that reputational harm will be inferred without a proper evidential basis.
Second, the decision highlights the statutory structure of copyright remedies under the Copyright Act. Arguments about “innocent” infringement under s 119(3), and the availability of additional damages under s 119(4), are fact-sensitive and evidence-driven. For defendants, the case supports the proposition that prompt rectification and lack of knowledge (if established) can materially affect the quantum and type of damages. For plaintiffs, it emphasises the need to plead and prove the basis for any licence-fee valuation and to substantiate claims for additional or exemplary damages.
Legislation Referenced
- Copyright Act (Cap 63, 2006 Rev Ed) — including ss 119(3) and 119(4)
- Trade Marks Act (Singapore) — as referenced in the metadata and in the court’s discussion of statutory damages principles
- Australian Copyright Act 1968 (as referenced in the metadata)
Cases Cited
- [2004] SGHC 76
- [2005] SGHC 183
- [2014] SGHCR 11
- [2015] SGHCR 15
- [2016] SGHCR 5
Source Documents
This article analyses [2016] SGHCR 5 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.